281 related articles for article (PubMed ID: 1641071)
1. Divergent effects of glucocorticoid on the gene expression of vasoactive intestinal peptide in the rat cerebral cortex and pituitary.
Lam KS; Srivastava G; Tam SP
Neuroendocrinology; 1992 Jul; 56(1):32-7. PubMed ID: 1641071
[TBL] [Abstract][Full Text] [Related]
2. Prolactin gene expression and secretion during pregnancy and lactation in the rat: role of dopamine and vasoactive intestinal peptide.
Escalada J; Cacicedo L; Ortego J; Melian E; Sánchez-Franco F
Endocrinology; 1996 Feb; 137(2):631-7. PubMed ID: 8593812
[TBL] [Abstract][Full Text] [Related]
3. Estrogen regulates the gene expression of vasoactive intestinal peptide in the anterior pituitary.
Lam KS; Srivastava G; Lechan RM; Lee T; Reichlin S
Neuroendocrinology; 1990 Nov; 52(5):417-21. PubMed ID: 2126350
[TBL] [Abstract][Full Text] [Related]
4. Autocrine/paracrine action of pituitary vasoactive intestinal peptide on lactotroph hyperplasia induced by estrogen.
Gómez O; Balsa JA
Endocrinology; 2003 Oct; 144(10):4403-9. PubMed ID: 12960047
[TBL] [Abstract][Full Text] [Related]
5. Regulation of hypothalamic and pituitary corticotropin-releasing hormone receptor messenger ribonucleic acid by adrenalectomy and glucocorticoids.
Luo X; Kiss A; Rabadan-Diehl C; Aguilera G
Endocrinology; 1995 Sep; 136(9):3877-83. PubMed ID: 7649095
[TBL] [Abstract][Full Text] [Related]
6. The immunostaining for the hypothalamic vasoactive intestinal peptide, but not for beta-endorphin, dynorphin-A or methionine-enkephalin, is affected by the glucocorticoid milieu in the rat: correlation with the prolactin secretion.
Watanobe H
Regul Pept; 1990 May; 28(3):301-11. PubMed ID: 1974081
[TBL] [Abstract][Full Text] [Related]
7. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
[TBL] [Abstract][Full Text] [Related]
8. Preferential increase in pituitary prolactin versus vasoactive intestinal peptide as a function of estradiol benzoate dose in the ovariectomized rat.
Carrillo AJ; Doherty PC; Guan XB; Sturtevant JR; Walro DG
Endocrinology; 1991 Jan; 128(1):131-8. PubMed ID: 1986914
[TBL] [Abstract][Full Text] [Related]
9. Transcription of the vasoactive intestinal peptide gene in response to glucocorticoids: differential regulation of alternative transcripts is modulated by a labile protein in rat anterior pituitary.
Chew LJ; Burke ZD; Morgan H; Gozes I; Murphy D; Carter DA
Mol Cell Endocrinol; 1997 Jun; 130(1-2):83-91. PubMed ID: 9220024
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive intestinal polypeptide mRNA and peptide levels are decreased in the anterior pituitary of the human growth hormone-releasing hormone transgenic mouse.
Hyde JF; Morrison DG; Drake KW; Moore JP; Maley BE
J Neuroendocrinol; 1996 Jan; 8(1):9-15. PubMed ID: 8932732
[TBL] [Abstract][Full Text] [Related]
11. Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/beta-lipotropin precursor mRNA in the pituitary in rats.
Jingami H; Matsukura S; Numa S; Imura H
Endocrinology; 1985 Oct; 117(4):1314-20. PubMed ID: 2992910
[TBL] [Abstract][Full Text] [Related]
12. The influence of adrenal hormone status on neuroendocrine peptides in the rat anterior pituitary gland.
Jones PM; O'Halloran DJ; Ghatei MA; Domin J; Bloom SR
J Endocrinol; 1990 Dec; 127(3):437-44. PubMed ID: 1704043
[TBL] [Abstract][Full Text] [Related]
13. Induction of vasoactive intestinal peptide gene expression and prolactin secretion by insulin-like growth factor I in rat pituitary cells: evidence for an autoparacrine regulatory system.
Lara JI; Lorenzo MJ; Cacicedo L; Tolón RM; Balsa JA; López-Fernández J; Sánchez-Franco F
Endocrinology; 1994 Dec; 135(6):2526-32. PubMed ID: 7988440
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide stimulates prolactin mRNA expression in turkey pituitary cells: effects of dopaminergic drugs.
Xu M; Proudman JA; Pitts GR; Wong EA; Foster DN; el Halawani ME
Proc Soc Exp Biol Med; 1996 May; 212(1):52-62. PubMed ID: 8618952
[TBL] [Abstract][Full Text] [Related]
15. Quantification of vasoactive intestinal peptide immunoreactivity in the anterior pituitary glands of intact male and female, ovariectomized, and estradiol benzoate-treated rats.
Carrillo AJ; Phelps CJ
Endocrinology; 1992 Aug; 131(2):964-9. PubMed ID: 1639033
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide in the hypothalamus and pituitary.
Lam KS
Neuroendocrinology; 1991; 53 Suppl 1():45-51. PubMed ID: 1901391
[TBL] [Abstract][Full Text] [Related]
17. Dopamine infusion into the third ventricle increases gene expression of hypothalamic vasoactive intestinal peptide and pituitary prolactin and luteinizing hormone beta subunit in the turkey.
Bhatt R; Youngren O; Kang S; El Halawani M
Gen Comp Endocrinol; 2003 Jan; 130(1):41-7. PubMed ID: 12535623
[TBL] [Abstract][Full Text] [Related]
18. Effect of thyroid hormones on vasoactive intestinal polypeptide gene expression in the rat cerebral cortex and anterior pituitary.
Buhl T; Georg B; Nilsson C; Mikkelsen JD; Wulff BS; Fahrenkrug J
Regul Pept; 1995 Feb; 55(3):237-51. PubMed ID: 7761623
[TBL] [Abstract][Full Text] [Related]
19. Para-chlorophenylalanine treatment inhibits the expression of vasoactive intestinal peptide messenger RNA in rat anterior pituitary.
Signs SA; Dluzen DE; Carrillo AJ
Brain Res Mol Brain Res; 1993 Jan; 17(1-2):36-40. PubMed ID: 8381907
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone regulates vasoactive intestinal peptide (VIP) mRNA levels in the rat anterior pituitary gland.
Segerson TP; Lam KS; Cacicedo L; Minamitani N; Fink JS; Lechan RM; Reichlin S
Endocrinology; 1989 Oct; 125(4):2221-3. PubMed ID: 2791988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]